Survival rate of liver cancer after the two academicians join hands is expected to increase significantly

On November 29, 2008, over 20 prominent Chinese experts, including Wu Mengchao, a member of the Chinese Academy of Sciences, met in Shanghai to attend a special symposium on the prevention of postoperative metastasis and recurrence of liver cancer within the framework of the National Special Infectious Disease Prevention and Control Project. The discussion focused on the potential of Likatin, a novel treatment approach, to significantly improve outcomes for liver cancer patients. Experts expressed optimism that this research could lead to longer progression-free survival and enhanced overall survival rates. Primary liver cancer remains one of the most deadly cancers in China, ranking as the second leading cause of cancer-related deaths. Despite surgical removal, the high rate of recurrence has not led to significant improvements in long-term survival. Controlling recurrence and metastasis is therefore a critical challenge in improving the overall success of liver cancer treatments. Since 1982, the Cell Engineering Center at the Fourth Military Medical University, led by Academician Chen Zhinan of the Chinese Academy of Engineering, has conducted extensive research into the use of iodine-131-labeled rituximab (Likatin). Their findings revealed that this compound can selectively target liver cancer cells, with the radioactive iodine effectively destroying them. Clinical trials showed an impressive response rate of 86.3%. A separate study involving liver cancer patients who underwent surgery demonstrated that those treated with Likatin had a 30.4% lower recurrence rate and a 20.6% higher survival rate compared to the control group. Patients also maintained normal levels of alpha-fetoprotein for a longer period, and no significant drug-related side effects were observed. According to recent reports, a multi-center, large-sample clinical trial is now being planned to further evaluate the effectiveness of Likatin in preventing liver cancer recurrence after surgery. This study is expected to provide more robust evidence and potentially pave the way for broader clinical application.

Whitening Raw Materials

Multiple factors must be considered when choosing whitening ingredients to ensure that the ideal whitening effect is achieved.
First of all, in terms of efficacy, raw materials with obvious whitening effects should be selected. For example, vitamin C can inhibit the generation of melanin, arbutin can reduce the deposition of melanin, glutathione, Azelaic Acid, Coenzyme Q10, MCC, Tranexamic Acid,
and ferulic acid have antioxidant effects. These ingredients are effective in brightening the skin and lightening spots.
Second, security is Paramount. Choose non-irritating to skin, and non-toxic raw materials, to avoid excessive skin stimulation due to improper use, causing allergies and other problems. In this way, we can ensure that while pursuing whitening, it will not cause harm to the skin.
In addition, stability is also a key concern. The selection of stable raw materials can avoid the loss of whitening effect during the production process or storage to ensure the quality and durability of the product.
In addition, air permeability can not be ignored. The selection of good breathable raw materials can make it better penetrate the skin surface and play a whitening effect. Different skin types and needs may require different combinations of raw materials, so careful consideration and selection need to be made according to the specific situation to achieve the best whitening results.
In short, only on the basis of fully considering factors such as efficacy, safety, stability, and breathability, combined with different skin types and needs, a reasonable selection of whitening raw materials can truly achieve effective whitening and make the skin glow healthy and beautiful.


Whitening Raw Materials,Azelaic Acid,Coenzyme Q10,Glutathione,MCC,Tranexamic Acid

Shaanxi Changsheng Industrial Co., Ltd. , https://www.cncsbio.com